News
Largest health research programme enlists 1 million volunteers

Our Future Health collects and links genetic and other health data in an effort to help people live longer and healthier lives.
Our Future Health is now over a fifth of the way towards its goal of recruiting 5 million volunteers, with around 3,000 new people joining every day.
The programme – which brings together the public sector, life sciences companies and leading UK health charities – is creating a detailed picture of health in the UK by collecting and linking genetic and other health data for millions of people.
This will enable researchers to find breakthroughs that help revolutionise the way diseases are detected, treated and prevented. The programme aims to “transform healthcare around the world” and help millions of people live longer and healthier lives.
Dr Raghib Ali, chief medical officer of Our Future Health, said: “From developing the first vaccine to understanding the structure of DNA, the UK has a history of leading the world in health research. Over the last year, it has been hugely inspiring to see people signing up in their hundreds of thousands to help write the next chapter in that story.
“While the breakthroughs of the past were often due to the brilliance of individuals, the breakthroughs of the future will rely on a large group of people who are united by their collective determination to play their part in making positive change. Each one of those million volunteers is contributing to creating a world-leading resource that will lead to discoveries that will save lives.
“But as far as we’ve come in the last year, we have even further still to go. We need another 4 million volunteers before we can fully harness the potential for using health data to make lifesaving discoveries.”
Our Future Health is particularly focused on recruiting volunteers from ethnic minorities and more deprived communities as these have been under-represented in health research in the past.
Our Future Health also now has the largest number of volunteers from more deprived backgrounds and ethnic minority groups of any UK health research programme.
Dr Ali said: “The relative lack of diversity in previous research has meant that those who are most likely to benefit from medical research are also the least likely to take part, further widening health inequalities. Our Future Health is committed to changing that by ensuring that the programme enables everyone to live longer, healthier lives, which is why it’s so important that people of all backgrounds take part.”
Anyone over 18 can volunteer by signing up online. Participants are asked to complete an online health questionnaire followed by a clinic appointment.
At the appointment, which are held in pharmacies and in mobile clinics that travel around the country, volunteers give a blood sample and some physical measurements are taken. They are also offered information about their own health, including their blood pressure and cholesterol levels.
In the future, volunteers will be given the option to receive feedback about their risk of some diseases and have the chance to take part in further research studies.
“When we started Our Future Health, we set out to create a health research programme on a scale never seen before anywhere in the world. Hitting one million volunteers over the last year is a truly remarkable achievement and means we’re now rapidly turning that ambition into reality,” said Professor Sir John Bell, chair of Our Future Health.
“And with thousands more people joining every day, we can now be very confident Our Future Health will become the most powerful research tool we’ve ever had to tackle chronic diseases. It will enable discoveries that help us change our health system from one where we mostly treat people who are already sick, to one where we can do much more to stop people becoming sick in the first place.”
Volunteers who don’t live near a location where Our Future Health clinic appointments are currently available can join now and be notified when new clinic locations become available. New locations will be announced on the Our Future Health website and social media channels.
News
Gut-friendly foods may damage heart, charity warns
News
Diabetes patients face increased risk of undiagnosed heart failure

People with diabetes may have undiagnosed heart failure that could be detected by a simple screening blood test, research suggests.
The TARTAN-HF trial found that one in four patients with diabetes who had at least one other risk factor for heart failure had undiagnosed heart failure detected through screening with a blood test and ultrasound scanning of the heart.
Experts said the findings show the extent of unrecognised heart failure in people with diabetes, and how the condition can be detected using a widely available blood test called NT-proBNP, which measures how much strain the heart is under.
They suggest a heart failure screening programme for diabetics could improve diagnosis rates, lead to earlier treatment and potentially reduce the risk of hospitalisation and death.
The study, involving 700 patients, was led by the University of Glasgow in collaboration with AstraZeneca, Roche Diagnostics, Us2.ai, NHS Greater Glasgow and Clyde and NHS Lanarkshire.
Dr Kieran Docherty, clinical senior lecturer at the University of Glasgow’s School of Cardiovascular and Metabolic Health, said: “Our results from the landmark TARTAN-HF trial identified heart failure in a large proportion of people living with diabetes, emphasising the need for a heart failure screening strategy in this group of patients.
“We know that many of the symptoms and signs of heart failure are non-specific, and may go unrecognised as potentially being due to heart failure for a long time.
“The strategy used in our trial is simple and easy to implement in clinical practice, and will aid in the early identification of heart failure in people with diabetes, and facilitate the initiation of medications that we know improve outcomes in patients with heart failure.”
The study, which began more than three years ago, involved more than 700 people with diabetes from the two health board areas who had at least one other risk factor for heart failure.
They were randomly assigned either to receive heart failure screening or to continue with their usual care.
Researchers found screening uncovered a large number of previously unrecognised cases of heart failure. Around one in four, or 24.9 per cent, of those screened were found to have the condition within six months, compared with 1 per cent in the group continuing their usual care.
The study, involving patients with type 1 and type 2 diabetes, found almost all of the participants found to have heart failure had preserved ejection fraction, which can be difficult to detect without dedicated testing.
The findings of the TARTAN-HF trial were presented at the American College of Cardiology conference taking place from 28 to 30 March in New Orleans in the US.
Dr Edward Piper, medical director at AstraZeneca UK, said: “Delayed diagnosis and treatment of heart failure in people with type 2 diabetes contributes to poor long-term outcomes. TARTAN-HF demonstrates that targeted, risk-based screening can identify previously undiagnosed heart failure in approximately one in four high-risk patients with diabetes, enabling earlier intervention with guideline-directed therapy.”
Dr Christian Simon, head of global medical affairs at Roche Diagnostics, said: “We are proud to have supported the landmark TARTAN-HF trial. These findings demonstrate the transformative power of early, accessible diagnostics like the NT-proBNP blood test.
“By identifying unrecognised heart failure in people with diabetes, we enable clinicians to initiate appropriate treatments sooner, ultimately improving patient outcomes and lives.”
News
UK government announces £6.3m fund to boost men’s health

The UK has launched a £6.3m men’s health fund to back local projects aimed at helping men and boys live longer, healthier lives.
The Men’s Health Community Fund is a partnership between the Department of Health and Social Care, Movember and People’s Health Trust.
The government is contributing £3m, while the two charities are more than doubling that to take the total to £6.3m.
Grants will support community projects reaching underserved men and boys aged 16 and over, particularly in the most disadvantaged areas and at key points in their lives such as becoming a father, losing a job or retiring.
Projects could include support for new fathers, activities for men facing loneliness and social isolation, services to help young men engage with the health system, and support for men in work, out of work and moving into retirement.
The programme will bring together voluntary, community and social enterprise organisations to test new ways of reaching men who are least likely to use traditional health services.
An evaluation funded through the National Institute for Health and Care Research will assess what works and help inform future policy and delivery.
Health and social care secretary Wes Streeting said: “Too many men across the country are living shorter, less healthy lives, particularly those in our most disadvantaged communities.
“This new partnership will help men get the support they need in the places they feel most comfortable, their communities, among people they trust.
“By working with expert charities and local organisations, we can reach the men who are too often missed by traditional services and help them take better care of their mental and physical health.”
“It is a key step in delivering our first ever Men’s Health Strategy and driving forward our ambition to halve the gap in healthy life expectancy between the richest and poorest areas.”
The Men’s Health Strategy sets out plans to tackle the physical and mental health challenges men and boys face.
Men can be less likely to seek help and more likely to suffer in silence, while higher rates of smoking, drinking, gambling and drug use are damaging men’s health and affecting families, workplaces and communities.
The government is also investing £3.6m over the next three years in suicide prevention projects for middle-aged men in local communities across areas of England where men are most at risk, many of which are also among the most deprived. Suicide is one of the biggest killers of men under 50, and three-quarters of all suicides are men.
The projects will aim to break down barriers middle-aged men face in seeking support, including stigma around asking for help and a lack of awareness of what is available and how to access it.
They will be co-designed with experts and men with lived experience of mental health crises and suicidal thoughts.













